Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
Per Kongsted, Troels Holz Borch, Eva Ellebæk, et al.
Cytotherapy (2017) Vol. 19, Iss. 4, pp. 500-513
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 4, pp. 261-279
Open Access | Times Cited: 3551
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
Cathrine Lund Lorentzen, John B.A.G. Haanen, Özcan Met, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 10, pp. e450-e458
Open Access | Times Cited: 327
mRNA therapeutics in cancer immunotherapy
Jan D. Beck, Daniel Reidenbach, Nadja Salomon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 278
Natural products and their derivatives: Promising modulators of tumor immunotherapy
Lijuan Deng, Ming Qi, Nan Li, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 493-508
Open Access | Times Cited: 157
Clinical and immunological effects of mRNA vaccines in malignant diseases
Annkristin Heine, Stefan Juranek, Peter Brossart
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 124
Anti-cancer peptide-based therapeutic strategies in solid tumors
Mohsen Karami Fath, Kimiya Babakhaniyan, Maryam Zokaei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 101
Current Developments and Challenges of mRNA Vaccines
Jinjin Chen, Jianzhu Chen, Qiaobing Xu
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 85-109
Open Access | Times Cited: 75
Advances in dendritic cell vaccination therapy of cancer
Sajad Najafi, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114954-114954
Open Access | Times Cited: 53
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 50
Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy
Yuebao Zhang, Xucheng Hou, Shi Du, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1364-1374
Closed Access | Times Cited: 48
Cancer mRNA vaccines: clinical advances and future opportunities
Elias Sayour, David Boczkowski, Duane A. Mitchell, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 489-500
Closed Access | Times Cited: 43
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten, Jolien Ceusters, An Coosemans, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. 1638212-1638212
Open Access | Times Cited: 134
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
Andrew B. Nixon, Kurt A. Schalper, Ira Jacobs, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 130
Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
Sarah Sutherland, Xinsheng Ju, Lisa G. Horvath, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Maryam Bidram, Yue Zhao, Natalia G. Shebardina, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1060-1060
Open Access | Times Cited: 68
Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives
Keywan Mortezaee
Life Sciences (2021) Vol. 277, pp. 119627-119627
Closed Access | Times Cited: 60
Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
Lijuan Duan, Qian Wang, Cuilian Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
Wei Jiao, Ai‐Min Hui
Cancer Treatment Reviews (2022) Vol. 107, pp. 102405-102405
Open Access | Times Cited: 42
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
Yuan Yuan, Fan Gao, Ying Chang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 38
The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26971-e26971
Open Access | Times Cited: 11
Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment
Santhosh Kalash Rajendrakumar, Saji Uthaman, Chong-Su Cho, et al.
Biomacromolecules (2018) Vol. 19, Iss. 6, pp. 1869-1887
Closed Access | Times Cited: 71
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
Mandy van Gulijk, Floris Dammeijer, Joachim G.J.V. Aerts, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 67
Correlates of immune and clinical activity of novel cancer vaccines
Sjoerd H. van der Burg
Seminars in Immunology (2018) Vol. 39, pp. 119-136
Open Access | Times Cited: 63
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
Jan Dörrie, Niels Schaft, Gerold Schuler, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 92-92
Open Access | Times Cited: 61
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Robert A. Belderbos, Joachim G.J.V. Aerts, Heleen Vroman
Molecular Therapy — Oncolytics (2019) Vol. 13, pp. 67-81
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top